Precision Business Insights
Portfolio

 

Research Reports

Global Vagus Nerve Stimulation Market – Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Vagus Nerve Stimulation (VNS) Market: By Form (Implantable VNS Devices, External VNS Devices), By Indication (Depression, Epilepsy, Migraine, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe) – Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Vagus Nerve Stimulation Market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.

 

Market Outline: Vagus Nerve Stimulation Market

Vagus nerve stimulation (VNS) is a sort of neuromodulation. It is intended to change how mind cells function by giving electrical incitement to specific regions associated with seizures. The vagus nerve is a piece of the autonomic sensory system, which controls elements of the body that are not under willful control, (for example, heart rate and relaxing). The vagus nerve sends data from the mind to different regions of the body. It additionally conveys data from the body to the cerebrum.

 

Market Dynamics: Vagus Nerve Stimulation Market 

Ascend in commonness of neurological and cardiovascular issue, increment in geriatric populace, development in help from government and private associations, and presentation of positive repayment arrangements drive the market. In any case, surprising expense of these gadgets and complexities related with vagus nerve stimulation devices market limit the market development. Moreover, high selection rate of negligibly obtrusive VNS methodology and improvement of cutting edge treatments for neurological scatters drive the market development amid the gauge time frame. Nonetheless, mind-boggling expense of gadgets, high support and entanglement identified with vagus nerve stimulation, and stringent administrative endorsements for these gadgets are limiting the development of the global VNS Market.

 

Market Scope: Vagus Nerve Stimulation Market 

Vagus Nerve Stimulation Market is classified on the basis of type, indication, end user and geographical regions.

Based on Type, vagus nerve stimulation market is segmented into

  • Implantable VNS Devices
  • External VNS Devices

Based on Indication, vagus nerve stimulation market is segmented into

  • Depression
  • Epilepsy
  • Migraine
  • Others

Based on End User, vagus nerve stimulation market is segmented into

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

 

Market Summary: Vagus Nerve Stimulation Market 

Global VNS market is modestly aggressive and broadened because of the nearness of an extensive number of territorial and universal sellers over the globe. These sellers go up against each other in view of components, for example, forceful valuing, item affectability, item separation, innovation update, and administration models. Moreover, a few market players are progressively concentrating on entering associations to grow new items and improve the aggressiveness.

 

Regional Analysis: Vagus Nerve Stimulation Market 

Geographically vagus nerve stimulation (VNS) market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America rules the global vagus nerve stimulation devices because of expanding inclination by medicinal services authorities of the locale for vagus nerve stimulation devices market. Also, the nearness of good repayment arrangements, accessibility of created human services foundation, and expanded patient mindfulness are factors boosting the market development for vagus nerve stimulation devices market. North America is trailed by Europe. Asia Pacific is a developing business sector for vagus nerve stimulation devices market. China and India are relied upon to be the quickest developing markets because of increment in social insurance use, ascend in government activity and use increment in quiet pool, and development in persistent mindfulness. Be that as it may, in areas, for example, Middle East and Africa, factors, for example, mind-boggling expense of treatment, absence of accessibility of created human services foundation, and poor patient instruction are controlling the development of the vagus nerve stimulation market.

 

Market participants: Vagus Nerve Stimulation Market 

Some of the players in Vagus Nerve Stimulation Market

  • Medtronic, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Jude Medical, Inc. (U.S.)
  • Synapse Biomedical, Inc. (U.S.)
  • Nevro Corporation (U.S.)
  • Neurosigma, Inc. (U.S.)
  • Neuropace, Inc. (U.S.)
  • Neuronetics, Inc. (U.S.)
  • Cyberonics, Inc. (U.S.)
  • BioControl Medical (Israel)
  • Medtronic, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Jude Medical, Inc. (U.S.)
  • Synapse Biomedical, Inc. (U.S.)
  • Nevro Corporation (U.S.)
  • Neurosigma, Inc. (U.S.)
  • Neuropace, Inc. (U.S.)
  • Neuronetics, Inc. (U.S.)
  • Cyberonics, Inc. (U.S.)
  • BioControl Medical (Israel)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Contact SalesTOLL FREE: +1-866-598-1553